DS Healthcare Group Introduces Revita Styling Products

Pompano Beach, Fla., March 24, 2015 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ:DSKX), today will introduce Revita styling products to its current line of Revita treatment products. These products have been designed to complement the Company's existing industry-leading hair care and topical treatment products that promote healthy hair growth.

Ordinary styling products typically produce a cosmetic effect while also containing ingredients which may be harmful to the scalp and clog pores, which can lead to additional hair loss conditions. The new line extension from DS Healthcare has been developed to be scalp safe with additional compounds added to enhance results from other DS Healthcare treatments. These products are the result of findings from DS Healthcare Group's ongoing clinical research on hair loss and related conditions.

"Revita styling products are formulated completely free of any toxic ingredients and are completely safe for use on the scalp and will not clog pores. Therefore these products can be safely used by anyone looking to maintain optimal scalp health and can be used with any existing DS Healthcare hair loss treatments such as Spectral. These products also contain therapeutic concentrations of active ingredients for optimal hair health," stated DS Healthcare President and CEO Daniel Khesin.

The new products can be seen here

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.

CONTACT: Daniel Khesin President and CEO DS Healthcare Group, Inc. 347.276.2598

Source:DS Healthcare Group,Inc.